Resultados de la búsqueda 31-40 of 14194 for Severe malaria

  1. Mayo Clinic Physician Update - August 2024

    Page 1.

  2. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  3. Untitled

    Page 1.

  4. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  7. Mayo Clinic Digestive Diseases Physician Update - May 2023

    Page 1.

  8. Clinical Update - July 2009 - MC2024-0709

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

  10. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    Immunity to Hepatitis B through vaccination in patients with inflammatory bowel disease and chronic liver disease is crucial due to high risk of morbidity. Part ...